MRK vs NVO
Merck & Company Inc · Novo Nordisk A/S
Relative return (rebased to 100)
Key stats
| Metric | MRK | NVO |
|---|---|---|
| Price | $135.17 | $45.71 |
| Market Cap | $333.85B | $203.14B |
| P/E | 18.29 | — |
| P/B | 7.28 | — |
| P/S | 5.14 | — |
| ROE | 39.8% | — |
| Net Margin | 28.1% | — |
| Gross Margin | — | — |
| Revenue Growth | 1.3% | — |
| Dividend Yield | 2.43% | — |
| EPS | $7.39 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.